US Direct Anterior Market Segmentation
US Direct Anterior Approach Type Outlook (USD Billion, 2018-2032)
S. Total Hip Replacement by DAA
S. Total Hip Replacement Market for DAA by ASC
1 Report Prologue
2 Market Introduction
2.1 Introduction 11
2.2 Assumptions & Limitations 11
3 Research Methodology
3.1 Research Process 13
3.2 Primary Research 13
3.3 Secondary Research 13
3.4 Market Size Estimation 14
4 Market Dynamics
4.1 Introduction 16
4.2 Drivers 16
4.2.1 Increasing Prevalence Osteoarthritis 16
4.2.2 Growing Geriatric Population 16
4.2.3 Rising R&D By The Key Players Of The Market 17
4.2.4 Favourable Reimbursement Policies 17
4.2.5 Drivers Impact Analysis 17
4.3 Restraints 18
4.3.1 High Cost Of Total Hip Arthroplasty 18
4.3.2 Incidence Of Product Recalls 18
4.3.3 Restraints Impact Analysis 18
4.4 Opportunity 19
4.4.1 Rising Demands For The Minimally Invasive Surgical Procedures 19
4.5 Macroeconomic Indicator 19
4.6 Product Trends In The U.S Direct Anterior Approach (Total Hip Replacement) Market In ACS 19
4.7 Trends In The U.S Direct Anterior Approach (Total Hip Replacement) Market In ACS 20
5 Market Factor Analysis
5.1 Value Chain Analysis 22
5.1.1 R&D And Designing 22
5.1.2 Manufacturing 22
5.1.3 Distribution & Sales 22
5.1.4 Post-Sales Review 23
5.2 Porter’s Five Forces Model 23
5.2.1 Bargaining Power Of Suppliers 24
5.2.1 Bargaining Power Of Buyers 24
5.2.2 Threat Of New Entrants 24
5.2.3 Threat Of Substitutes 24
5.2.4 Intensity Of Rivalry 24
5.3 Investment Opportunities 24
5.4 Pricing Analysis 25
5.5 Demand & Supply: Gap Analysis 25
6 U.S Direct Anterior Approach (Total Hip Replacement) Market
6.1 Total Hip Replacement 27
6.1.1 Total Hip Replacement By DAA (Direct Anterior Approach) 28
7 Competitive Landscape
7.1 Competitive Landscape 31
7.1.1 Ambulatory Surgical Centers 32
7.1.1.1 Introduction 32
8 Company Profile
8.1 Johnson & Johnson Services Inc. (DePuy Synthes) 34
8.1.1 Company Overview 34
8.1.2 Financial Overview 34
8.1.3 Products Offering 35
8.1.4 Key Developments 35
8.1.5 SWOT Analysis 35
8.1.6 Key Strategy 35
8.2 Stryker 36
8.2.1 Company Overview 36
8.2.2 Financial Overview 36
8.2.3 Products Offering 37
8.2.4 Key Developments 37
8.2.5 SWOT Analysis 37
8.2.6 Key Strategy 37
8.3 Zimmer Biomet 38
8.3.1 Company Overview 38
8.3.2 Financial Overview 38
8.3.3 Products Offering 39
8.3.4 Key Developments 39
8.3.5 SWOT Analysis 40
8.3.6 Key Strategy 40
8.4 Smith & Nephew 41
8.4.1 Company Overview 41
8.4.2 Financial Overview 41
8.4.3 Products Offering 42
8.4.4 Key Developments 42
8.4.5 SWOT Analysis 42
8.4.6 Key Strategy 43
8.5 OrthAlign, Inc. 44
8.5.1 Company Overview 44
8.5.2 Financial Overview 44
8.5.3 Products Offering 44
8.5.4 Key Developments 44
8.5.5 SWOT Analysis 44
8.5.6 Key Strategy 45
8.6 Proliance Surgeons 46
8.6.1 Company Overview 46
8.6.2 Financial Overview 46
8.6.3 Products Offering 46
8.6.4 Key Developments 46
8.6.5 SWOT Analysis 46
8.6.6 Key Strategy 46
8.7 The Hip And Knee Center 47
8.7.1 Company Overview 47
8.7.2 Financial Overview 47
8.7.3 Products Offering 47
8.7.4 Key Developments 47
8.7.5 SWOT Analysis 47
8.7.6 Key Strategy 47
8.8 Centre For Special Surgery 48
8.8.1 Company Overview 48
8.8.2 Financial Overview 48
8.8.3 Products Offering 48
8.8.4 Key Developments 48
8.8.5 SWOT Analysis 48
8.8.6 Key Strategy 48
8.9 Bone & Joint Surgery Clinic 49
8.9.1 Company Overview 49
8.9.2 Financial Overview 49
8.9.3 Products Offering 49
8.9.4 Key Developments 49
8.9.5 SWOT Analysis 49
8.9.6 Key Strategy 49
8.10 Orthoillinois 50
8.10.1 Company Overview 50
8.10.2 Financial Overview 50
8.10.3 Products Offering 50
8.10.4 Key Developments 50
8.10.5 SWOT Analysis 50
8.10.6 Key Strategy 50
9 List Of Tables
TABLE 1 U.S. TOTAL HIP REPLACEMENT MARKET 2023-2032 (USD MILLION) 28
TABLE 2 U.S. TOTAL HIP REPLACEMENT MARKET, BY NUMBER OF PROCEDURE 2023-2032 28
TABLE 3 U.S. TOTAL HIP REPLACEMENT BY DAA (DIRECT ANTERIOR APPROACH) 2023-2032 (USD MILLION) 29
TABLE 4 U.S. TOTAL HIP REPLACEMENT BY DAA, NUMBER OF PROCEDURE 2023-2032 (USD MILLION) 29
TABLE 5 U.S. TOTAL HIP REPLACEMENT MARKET FOR DAA BY AMBULATORY SURGICAL CENTERS ASC 2023-2032 (USD MILLION) 29
TABLE 6 TOP 3 U.S. AMBULATORY SURGICAL CENTER FOR THR (2023) 33
10 List Of Figures
FIGURE 1 RESEARCH PROCESS 14
FIGURE 2 DROC ANALYSIS OF THE U.S. DIRECT ANTERIOR APPROACH (TOTAL HIP REPLACEMENT) MARKET IN ASC 17
FIGURE 3 DRIVERS IMPACT ANALYSIS: U.S. DIRECT ANTERIOR APPROACH (TOTAL HIP REPLACEMENT) MARKET 18
FIGURE 4 RESTRAINTS IMPACT ANALYSIS: U.S. DIRECT ANTERIOR APPROACH (TOTAL HIP REPLACEMENT) MARKET 19
FIGURE 5 VALUE CHAIN: U.S. DIRECT ANTERIOR APPROACH (TOTAL HIP REPLACEMENT) MARKET 23
FIGURE 6 PORTER’S FIVE FORCES MODEL: THE U.S. DIRECT ANTERIOR APPROACH (TOTAL HIP REPLACEMENT) MARKET IN ASC 24
FIGURE 7 U.S. TOTAL HIP REPLACEMENT MARKET 2023 - 2032 (USD MILLION) 28
FIGURE 8 U.S. TOTAL HIP REPLACEMENT BY DAA (DIRECT ANTERIOR APPROACH) 2023 - 2032 (USD MILLION) 29
FIGURE 9 U.S. TOTAL HIP REPLACEMENT MARKET FOR DAA BY AMBULATORY SURGICAL CENTERS 2023 - 2032 (USD MILLION) 30
FIGURE 10 U.S. TOTAL HIP REPLACEMENT, MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2023 (%) 32
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
